CLDX
Celldex Therapeutics, Inc.
Biopharmaceutical company developing therapeutic antibodies for inflammatory, allergic, autoimmune, and other diseases
CUSIP: 15117B202HealthcareUS1 holder
Total Value
$63.03M
Total Shares
2.34M
Net Share Change
+491.2K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$63.03M2.34M shares
ADD+491.2K(+26.6%)